Druckansicht
 
 

The New Biology of Lung Cancer: Changing Paradigms in Personalized Medicine

Physicians Education Resource
Archiv
-
05.06.2010  Chicago
Not an official event of the ASCO Annual Meeting. Not sponsored or endorsed by ASCO or the ASCO Cancer Foundation.
 
Kursinhalte
CME-certified satellite symposium, will inform participants of the emerging diversity of lung cancer and the implications for individualized therapy. The newfound importance of biomarkers in treatment decision making will be emphasized, followed by other current topics of interest, such as maintenance therapy. Selected use of targeted agents, including EGFR and angiogenesis inhibitors, will be discussed, as will novel targets including EML4-ALK. Didactic lectures from lung cancer experts will...
Lernziele, Trainingsziele
Please see our websie for all the details www.cancerlearning.com
Zielpublikum
This educational program is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with lung cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health
Anmerkungen
http://www.cancerlearning.com/index.cfm/fuseaction/conference.showOverview/id/5/conference_id/541
 

Anfragen und Anmeldung:

Herr Duane Fowler
001 888 949 0045
 
Kategorien
Onkologie
Sprache
Englisch
Kosten
complimentary
Veranstalter Kontakt
3500 Maple Ave. Ste. 700
75219 Dallas
USA
Tel: 001 888 949 0045
Fax: 001 314 367 3305
info@cancerlearning.com
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Anästhesie in Entwicklungsländern e. V.Helix - Forschung & Beratung WienCenter of ExcellenceÄrzte der WeltAGEM - Arbeitsgemeinschaft Ethnomedizin e. V.Österreichische Gesellschaft für Public HealthÄrztekammer für WienCharité International Academy

Facebook

Sagen Sie uns Ihre professionelle Meinung

Zur Umfrage

Zur Umfrage